---
title: "Ofatumumab - Chronic Lymphoid Leukemia"
sidebar: mydoc_sidebar
permalink: db06650-mesh-d015451-1.html
toc: false 
---


Path ID: `DB06650_MESH_D015451_1`
{% include image.html url="images/db06650-mesh-d015451-1.png" file="db06650-mesh-d015451-1.png" alt="db06650-mesh-d015451-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C527517 | Ofatumumab | Drug |
| UniProt:P11836 | B-lymphocyte antigen CD20 | Protein |
| GO:0042100 | B cell proliferation | BiologicalProcess |
| MESH:D015451 | Chronic lymphoid leukemia, disease | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Ofatumumab | DECREASES ACTIVITY OF | B-Lymphocyte Antigen Cd20 |
| B-Lymphocyte Antigen Cd20 | POSITIVELY REGULATES | B Cell Proliferation |
| B Cell Proliferation | POSITIVELY CORRELATED WITH | Chronic Lymphoid Leukemia, Disease |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB06650#BE0000066](https://go.drugbank.com/drugs/DB06650#BE0000066)
